Suraksha Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suraksha program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suraksha Program Today - Breaking & Trending Today

Covid-19 booster dose iNCOVACC to enter India shortly, Bharat Biotech confirms

INCOVACC is now available on CoWin, and priced at Rs 800 for private markets and priced at Rs 325 for supplies to government of India and state governments.
....

Krishna Ella , Suraksha Program , Washington University , Technology Development Board , Ministry Of Health , Bharat Biotech International Limited , Central Drugs Standard Control Organization , Department Of Biotechnology , Bharat Biotech , Executive Chairman , Covid 19 , Bharat Biotech , Ncovacc Booster , Ncovacc Booster Dose ,

Nasal Vaccine Pricing Out, To be Rolled Out Around Last Week of January

INCOVACC is to be priced at INR 325 per dose for large volume procurement by State Governments and Govt of India, and INR 800 for Private Markets. ....

Andhra Pradesh , Krishna Ella , Suraksha Program , Washington University , Technology Development Board , Ministry Of Health , Bharat Biotech International Limited , Central Drugs Standard Control Organization , Department Of Biotechnology , Nasal Vaccine Pricing Out , Rolled Out Around Last Week , State Governments , Biotech International Limited , Bharat Biotech , Executive Chairman ,

COVID-19: Government approves nasal vaccine, will be available first in private hospitals

As of now, the situation is not alarming, so there is no need to panic, said a government press release. ....

United States , South Korea , Suraksha Program , Washington University , Bharat Biotech International Limited , Indian Medical Association , Central Drugs Standard Control Organisation , Department Of Biotechnology , Restricted Use , Emergency Situation , Medical Association , Covid 19 , Nasal Vacccine , Nasal Vaccine , Government Apporves Nasal Vaccine ,

Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be availabile in private hospitals

The central government has approved the use of Bharat Biotech nasal Covid vaccine iNCOVACC to be included in the country vaccination programme as a booster ....

United States , South Korea , New Delhi , Narendra Modi , Mansukh Mandaviya , Union Health , Union Health Ministry , Bharat Biotech International Limited , Central Drugs Standard Control Organisation , Department Of Biotechnology , Washington University , Suraksha Program , Bharat Biotech , Restricted Use , Emergency Situation , Union Health Minister Mansukh Mandaviya , Minister Narendra Modi , Prime Minister , Chief Ministers , Senior Officials , Europe News , He Preparedness , Prime Minister , Heterologous Booster , Nd Will , Whose Above ,

India made world's first COVID nasal vaccine gets approval: Dr Jitendra - Jammu Kashmir Latest News | Tourism

Excelsior Correspondent NEW DELHI, Dec 1 : World’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above. This was informed here today by Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh while chairing the meeting […] ....

New Delhi , Rajesh Gokhale , Narendra Modi , Atmanirbhar Bharat , Jitendra Singh , Atomic Energy , Bharat Biotech International Limited , Central Drugs Standard Control Organisation , Department Of Biotechnology , Earth Sciences , Suraksha Program , Biotechnology Research , Science Technology , National Education , National Institute Of Immunology New Delhi , Biotechnology Industry Research Assistance , Innovation Council , Union Minister Dr Jitendra Singh , Annual General Body Meeting , Autonomous Institutions , National Institute , Immunology New Delhi , Union Minister , Independent Charge , Public Grievances , Biotechnology Institutes ,